Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis

Marie C. Hupe, Christian Philippi, Doris Roth, +12

Frontiers in Oncology

Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer

Isabel Heidegger, Georgios Fotakis, Anne Offermann, +20

Molecular Cancer

Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer

Johannes Brägelmann, Niklas Klümper, Anne Offermann, +18

Clinical Cancer Research

KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells

Eric Metzger, Sheng Wang, Sylvia Urban, +18

Nature Structural & Molecular Biology

Cancer ResearchChromatinChromatin RemodelingMedicineControls Proliferation +9

Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion

Christian Watermann, Helen Pasternack, Christian Idel, +16

Clinical Cancer Research

Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade

Victoria Klepsch, Natascha Hermann‐Kleiter, Patricia Do-Dinh, +12

Nature Communications

The activation of OR51E1 causes growth suppression of human prostate cancer cells

Désirée Maßberg, Nikolina Jovancevic, Anne Offermann, +14

Oncotarget

Androgen ReceptorSignal TransductionFunctional SelectivityMedicineGrowth Suppression +13

Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma

Christiane Kümpers, Mladen Jokić, Ozan Haase, +6

Frontiers in Medicine

Checkpoint InhibitionImmunologyPathologyImmune Cell TherapyImmunotherapy +15

Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer

Finn Becker, Vincent Joerg, Marie C. Hupe, +11

International Journal of Cancer

UrologyOncologyGenitourinary CancerAggressive Prostate CancerMedicine +10

Somatic copy number alterations by whole‐exome sequencing implicates <i><scp>YWHAZ</scp></i> and <i><scp>PTK2</scp></i> in castration‐resistant prostate cancer

Roopika Menon, Mario C. Deng, Kerstin Rüenauver, +14

The Journal of Pathology

GeneticsAmplification FrequencyMolecular GeneticsGenomicsTumor Biology +16